Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study. - Wikidata - awgldk - TriplyDB

Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study.

Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study.

http://www.wikidata.org/entity/Q37580063

about

Comparing Prevalence Estimates From Population-Based Surveys to Inform Surveillance Using Electronic Health Records Generalizability of Indicators from the New York City Macroscope Electronic Health Record Surveillance System to Systems Based on Other EHR Platforms.

P2860

Q33787319-3C455EEC-B852-4ACF-96E8-7AA0AE1C4D97 Q55039942-C1D66C9C-992E-4F36-AC0C-1AE0A32BC9EB

P2860

Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study.

http://www.wikidata.org/entity/Q37580063

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Monitoring Prevalence, Treatme ...... Surveillance Validation Study.

@en

Monitoring Prevalence, Treatme ...... Surveillance Validation Study.

@nl

type

label

Monitoring Prevalence, Treatme ...... Surveillance Validation Study.

@en

Monitoring Prevalence, Treatme ...... Surveillance Validation Study.

@nl

prefLabel

Monitoring Prevalence, Treatme ...... Surveillance Validation Study.

@en

Monitoring Prevalence, Treatme ...... Surveillance Validation Study.

@nl

P1433

Q37580063-8F6AABCE-B6DC-400E-85DC-0FEF5181CB55

P1476

Q37580063-2E120CFC-4A94-4C06-AF97-5D9C1630C7C9

P2093

Q37580063-0C8A91FC-BB25-4C63-81EB-971E70D1578B

Q37580063-106C54C2-026E-4B81-AB8D-E0F8F2ED3FA5

Q37580063-339041A3-D1A8-45B4-B061-7569766A0661

Q37580063-3403D2AD-0CFF-42A8-97FE-7F61F163C6B0

Q37580063-3931001A-4070-45C0-815F-5FE3B3DB979D

Q37580063-EFB09885-247C-4D5B-A6E0-BFED0E971E24

Q37580063-F8D341ED-C4CA-46E1-9806-E49CECB898BD

P2860

Q37580063-053CEA9E-8ED6-4A27-9006-388A6E42703A

Q37580063-09C9465A-B326-487D-B9DA-34771D4DF11C

Q37580063-0C287A82-D5C3-40F7-BDD2-975379351E5D

Q37580063-1DE48C90-F6AF-4873-AA91-E7E8C83618C4

Q37580063-2540180B-405B-4367-85B8-C4915317F7C2

Q37580063-2BC99562-4EB7-4FD2-83FB-2910299460B5

Q37580063-3B76D25A-5E83-4439-903C-B9F1F5E22E20

Q37580063-3F0AC9F2-1A48-4F34-BCDD-2D09416A5287

Q37580063-48074046-AE2E-4556-B53A-E021961D0317

Q37580063-52BB36AE-B797-4BE4-9F14-5F4B18B05DA5

P304

Q37580063-9C67BDD4-44E3-4B8F-8C1C-538EBE8C3E0C

P31

Q37580063-371643F5-47FA-48BE-B511-92997471F3A5

P356

Q37580063-C93A969D-B7E2-4D9A-85C3-4AA724DAA04E

P433

Q37580063-4D640789-F34A-452C-81A5-21F71895E0D3

P478

Q37580063-C66C3082-2CDC-4278-A8AD-2168D64C8892

P50

Q37580063-E749AD2A-023B-4054-90DA-033C2F0FFE92

P577

Q37580063-AFC0F135-59D8-41D2-B72E-2D6DBC4CE5BB

P698

Q37580063-1999A6CE-E7DB-4C82-B850-A2718B07EB6E

P921

Q37580063-CE814D91-E3A7-4FCF-9240-6454732100FE

P932

Q37580063-6886246D-D108-49B0-878D-0E7D5F43D10A

P356

P1433

EGEMS (Washington, DC)

P1476

Monitoring Prevalence, Treatme ...... Surveillance Validation Study.

@en

P2093

Jesica Rodriguez-Lopez

http://www.w3.org/2001/XMLSchema#string

Katharine H McVeigh

http://www.w3.org/2001/XMLSchema#string

Katherine Bartley

http://www.w3.org/2001/XMLSchema#string

Lauren Schreibstein

http://www.w3.org/2001/XMLSchema#string

Lorna E Thorpe

http://www.w3.org/2001/XMLSchema#string

Pui Ying Chan

http://www.w3.org/2001/XMLSchema#string

Sharon Perlman

http://www.w3.org/2001/XMLSchema#string

P2860

Study design and participation rates of the New York City Health and Nutrition Examination Survey, 2004

The Hub Population Health System: distributed ad hoc queries and alerts

Understanding Equivalence and Noninferiority Testing

Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.

Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League Expert Committee.

Prevalence of chronic medical conditions in Switzerland: exploring estimates validity by comparing complementary data sources.

Metabolic syndrome in the Military Health System based on electronic health data, 2009-2012.

Validity of registration of ICD codes and prescriptions in a research database in Swedish primary care: a cross-sectional study in Skaraborg primary care database

Severity of obesity and management of hypertension, hypercholesterolaemia and smoking in primary care: population-based cohort study.

Validating the 8 CPCSSN case definitions for chronic disease surveillance in a primary care database of electronic health records

P304

1266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.13063/2327-9214.1266

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Remle Newton-Dame

P577

2016-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28154836

http://www.w3.org/2001/XMLSchema#string

P921

electronic health record

P932

5226388

http://www.w3.org/2001/XMLSchema#string